Manufacturer of Controlled Substances; Notice of Application; Siegfried (USA), LLC, 46613 [2013-18338]

Download as PDF Federal Register / Vol. 78, No. 148 / Thursday, August 1, 2013 / Notices DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Siegfried (USA), LLC Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 10, 2013, Siegfried (USA), LLC., 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Opium raw (9600) ........................ Poppy Straw Concentrate (9670) II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than September 30, 2013. Dated: July 23, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–18338 Filed 7–31–13; 8:45 am] BILLING CODE 4410–09–P Hampshire (subject firm). The negative determination was issued on June 14, 2013 and the Department’s Notice of determination was published in the Federal Register on July 2, 2013 (78 FR 39774). Workers at the subject firm were engaged in activities related to the production of electrical connectors and backplane assemblies. The initial investigation resulted in a negative determination based on the Department’s findings that sales and production at the subject firm increased during that period; that there was no shift in production to a foreign country or acquisition of production from a foreign country; that imports by the subject firm have decreased; that Amphenol Backplane Systems, Nashua, New Hampshire, is neither a Supplier nor Downstream Producer to a firm that employed a group of workers who received a certification of eligibility under Section 222(a) of the Act, 19 U.S.C. 2272(a); and that the workers’ firm has not been publicly identified by name by the International Trade Commission as a member of a domestic industry in an investigation resulting in an affirmative finding of serious injury, market disruption, or material injury, or threat thereof. The request for reconsideration alleges a shift in production/services to a foreign country, that the subject firm increased imports, that the subject firm experienced a loss of business with a TAA-certified firm, that the subject firm has factories in Mexico and China. The Department has carefully reviewed the request for reconsideration and the existing record, and will conduct further investigation to determine if the workers meet the eligibility requirements of the Trade Act of 1974, as amended. DEPARTMENT OF LABOR Conclusion Employment and Training Administration After careful review of the application, I conclude that the claim is of sufficient weight to justify reconsideration of the U.S. Department of Labor’s prior decision. The application is, therefore, granted. [TA–W–82,598] mstockstill on DSK4VPTVN1PROD with NOTICES Amphenol Backplane Systems, Nashua, New Hampshire; Notice of Affirmative Determination Regarding Application for Reconsideration By application dated June 24, 2013, workers requested administrative reconsideration of the negative determination regarding workers’ eligibility to apply for Trade Adjustment Assistance (TAA) applicable to workers and former workers of Amphenol Backplane Systems, Nashua, New VerDate Mar<15>2010 17:02 Jul 31, 2013 Jkt 229001 Signed at Washington, DC, this 22nd day of July 2013. Del Min Amy Chen, Certifying Officer, Office of Trade Adjustment Assistance. [FR Doc. 2013–18489 Filed 7–31–13; 8:45 am] BILLING CODE 4510–FN–P PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 46613 DEPARTMENT OF LABOR Employment and Training Administration [TA–W–82,442] Deluxe Laboratories, Inc., a Division of Deluxe Entertainment Services Group, Inc., Hollywood, California; Notice of Affirmative Determination Regarding Application for Reconsideration By application dated June 20, 2013, a state workforce official requested administrative reconsideration of the negative determination regarding workers’ eligibility to apply for Trade Adjustment Assistance (TAA) applicable to workers and former workers of Deluxe Laboratories, Inc., a division of Deluxe Entertainment Services Group, Inc., Hollywood, California (subject firm). The negative determination was issued on May 2, 2013 and the Notice of Determination was published in the Federal Register on May 24, 2013 (78 FR 31593–31596). Workers at the subject firm were engaged in activities related to the production of release and trailer prints. The initial investigation resulted in a negative determination based on the Department’s findings that with respect to Section 222(a)(2)(A)(ii) of the Act, imports of articles like or directly competitive with release and trailer prints have not increased from 2011 to 2012 or from 2012 to 2013 by the workers’ firm or customers of the workers’ firm. With respect to Section 222(a)(2)(B) of the Act, the investigation revealed that the workers’ firm did not shift the production of articles like or directly competitive with release and trailer prints to a foreign country or acquire like or directly competitive articles from a foreign country during 2011, 2012, or 2013. Rather, the investigation confirmed that the worker separations are attributable to decreased demand for movies and trailers that are printed on 35mm film. With respect to Section 222(b)(2) of the Act, the investigation revealed that Deluxe Laboratories, Inc. is not a Supplier or Downstream Producer to a firm that employed a group of workers who received a certification of eligibility under Section 222(a) of the Act, 19 U.S.C. 2272(a). Finally, the group eligibility requirements under Section 222(e) of the Act, have not been satisfied because the workers’ firm has not been publicly identified by name by the International Trade Commission as a member of a domestic industry in an investigation resulting in an affirmative finding of E:\FR\FM\01AUN1.SGM 01AUN1

Agencies

[Federal Register Volume 78, Number 148 (Thursday, August 1, 2013)]
[Notices]
[Page 46613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-18338]



[[Page 46613]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Siegfried (USA), LLC

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 10, 2013, Siegfried 
(USA), LLC., 33 Industrial Park Road, Pennsville, New Jersey 08070, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of the following basic classes 
of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Opium raw (9600)...........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR Sec.  1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than September 30, 2013.

    Dated: July 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-18338 Filed 7-31-13; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.